Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Controlled release of ocular biopharmaceuticals using bioresponsive protein polymers

Controlled release of ocular biopharmaceuticals using bioresponsive protein polymers

US Patent 9102763 · Granted Aug 11, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multimeric elastin-like polypeptides2025
Multimeric elastin-like polypeptides2022
Systems and methods for separating cannabis-derived compounds using chromatograp2022
Methods and therapeutics comprising ligand-targeted ELPs2022
Generation of hemoglobin-based oxygen carriers using elastin-like polypeptides2021
CD20 scFv-ELPs methods and therapeutics2021
Chiral separation of Δ8-THC, Δ9-THC, and related enantiomers using CO2-based chr2019
RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma2017
RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma2015
RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma2012
RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma2011
Injection aid for anterior juxtascleral depot2011